Correlation Between NYSE Composite and Cymabay Therapeu

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Cymabay Therapeu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Cymabay Therapeu into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and Cymabay Therapeu, you can compare the effects of market volatilities on NYSE Composite and Cymabay Therapeu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Cymabay Therapeu. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Cymabay Therapeu.

Diversification Opportunities for NYSE Composite and Cymabay Therapeu

-0.2

Correlation Coefficient

NYSE Composite  Cymabay Therapeu

Good diversification

The 3 months correlation between NYSE and Cymabay is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Cymabay Therapeu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cymabay Therapeu and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Cymabay Therapeu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cymabay Therapeu has no effect on the direction of NYSE Composite i.e., NYSE Composite and Cymabay Therapeu go up and down completely randomly.

Pair Corralation between NYSE Composite and Cymabay Therapeu

If you would invest  1,954,967  in NYSE Composite on October 26, 2024 and sell it today you would earn a total of  44,780  from holding NYSE Composite or generate 2.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.67%
Values	Daily Returns

NYSE Composite  vs.  Cymabay Therapeu

Pair Trading with NYSE Composite and Cymabay Therapeu

The main advantage of trading using opposite NYSE Composite and Cymabay Therapeu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Cymabay Therapeu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cymabay Therapeu will offset losses from the drop in Cymabay Therapeu's long position.

The idea behind NYSE Composite and Cymabay Therapeu pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.